A total of 530 results found based on your keywords
RF_ID | Disease Name | poly_category | variablesites | Species | RF_Name | Association | Condition | PMID |
---|---|---|---|---|---|---|---|---|
3826 | Parkinson disease | SNP | TMEM163 p.33P>R | Human | TMEM | RF | 33279243 | |
3825 | Parkinson disease | SNP | TMEM175 p.176 K>E | Human | TMEM | RF | 33279243 | |
4008 | Fatal familial insomnia (FFI) | SNP | rs169172 | Human | SRSF11 | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
4007 | Fatal familial insomnia (FFI) | SNP | rs647872 | Human | SRSF11 | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
4009 | Fatal familial insomnia (FFI) | SNP | rs10661326 | Human | SRSF11 | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
4000 | Fatal familial insomnia (FFI) | SNP | rs360609 | Human | NR1H9P | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
3999 | Fatal familial insomnia (FFI) | SNP | rs75631798 | Human | NR1H8P | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
3998 | Fatal familial insomnia (FFI) | SNP | rs360608 | Human | NR1H7P | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
3997 | Fatal familial insomnia (FFI) | SNP | rs360607 | Human | NR1H6P | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
3996 | Fatal familial insomnia (FFI) | SNP | rs360599 | Human | NR1H5P | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
4001 | Fatal familial insomnia (FFI) | SNP | rs360610 | Human | NR1H10P | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
4011 | Fatal familial insomnia (FFI) | SNP | rs60353063 | Human | MSANTD3 | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
4013 | Fatal familial insomnia (FFI) | SNP | rs73655549 | Human | MSANTD3 | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
4010 | Fatal familial insomnia (FFI) | SNP | rs57241635 | Human | MSANTD3 | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
4012 | Fatal familial insomnia (FFI) | SNP | rs10114432 | Human | MSANTD3 | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
4014 | Fatal familial insomnia (FFI) | SNP | rs1556487 | Human | MSANTD3 | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
4003 | Fatal familial insomnia (FFI) | SNP | rs2685151 | Human | GNA13P1 | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
4002 | Fatal familial insomnia (FFI) | SNP | rs1594400 | Human | GNA13P1 | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
4005 | Fatal familial insomnia (FFI) | SNP | rs1992813 | Human | EXOC1L | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
4004 | Fatal familial insomnia (FFI) | SNP | rs1447039 | Human | EXOC1L | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
4006 | Fatal familial insomnia (FFI) | SNP | rs1447049 | Human | EXOC1L | RF | These genetic variants are absent in FFI patients with early disease onset (19-40 years) | 37626863 |
1839 | Alzheimer's Disease | SNP | rs41453547 A5656G | Human | MT-ND2 | RF | 34854014 | |
1840 | Alzheimer's Disease | SNP | rs386420024 A13759G | Human | MT-ND5 | RF | 34854014 | |
3990 | Tourette Syndrome | SNP | rs35615695 | Human | ASH1L | RF | 35307981 | |
3989 | Tourette Syndrome | SNP | rs5005770 | Human | ASH1L | RF | 35307981 | |
470 | Multiple System Atrophy | SNP | rs11931074 (GG) | Human | SNCA + well water nondrinkers | PF | 35748722 | |
467 | Multiple System Atrophy | SNP | rs11931074 (tt) | Human | SNCA + alcohol nonusers | PF | 35748722 | |
468 | Multiple System Atrophy | SNP | rs148156462 (TT) | Human | COQ2 + current smokers | PF | 35748722 | |
466 | Multiple System Atrophy | SNP | rs148156462 (Tc) | Human | COQ2 + pesticide nonexposure | PF | 35748722 | |
1666 | Amyotrophic Lateral Sclerosis | SNP | 12q13.3(rs60565245) | Human | LRP1 | RF | 37142397 | |
1571 | Amyotrophic Lateral Sclerosis | SNP | 7p21.3(rs2354952) | Human | THSD7A | RF | 37142397 | |
1677 | Amyotrophic Lateral Sclerosis | SNP | 5q31.3(rs11738209) | Human | FGF1 | RF | 37142397 | |
1829 | Parkinson disease | SNP | rs3746106 5'-UTR | Human | MIDN | RF | 36858566 | |
3952 | Parkinson disease | SNP | rs1922452/A allelic variant | Human | CD4 | RF | 36224715 | |
3953 | Parkinson disease | SNP | rs951818/A | Human | CD4 | RF | 36224715 | |
3930 | Alzheimer's Disease | SNP | rs2421943 GG and AG genotypes | Human | IDE | RF | 35236268 | |
3904 | Alzheimer's Disease | SNP | minor allele of rs5025718 | Human | NOTCH2 | RF | 37355909 | |
3147 | Amyotrophic Lateral Sclerosis | SNP | Human | A90V TDP-43 variant | RF | 18505686 | ||
721 | Alzheimer's Disease | SNP | rs3752246 | Human | ABCA7 | PF | National Alzheimer’s Coordinating Center (NACC) cohort | 30128317 |
1942 | Alzheimer's Disease | SNP | rs3764650 G allele | Human | ABCA7 | RF | 26795201 | |
1974 | Alzheimer's Disease | SNP | rs3764650 | Human | ABCA7 | RF | Calculated by fixed effect model | 29504051 |
767 | Parkinson disease | SNP | TCG (rs3764650-rs3752246-rs4147929) haplotype | Human | ABCA7 | PF | 35709878 | |
2972 | Alzheimer's Disease | SNP | rs3764650 | Human | ABCA7 | RF | 29589097 | |
3955 | Parkinson disease | SNP | A allele of rs4147929 | Human | ABCA7 | RF | 35709878 | |
3149 | Alzheimer's Disease | SNP | rs142076058 | Human | ABCA7 | RF | 29589097 | |
3110 | Parkinson disease | SNP | g.116154T>C (rs28746504), g.117130A>G (rs2188524), g.117356C>G (rs34976462), g.117372T>C (rs3213619) | Human | ABCB1 | RF | 24572589 | |
546 | Alzheimer's Disease | SNP | rs2247071、rs2862616、rs3753526、rs1044925:CGCA Haplotype | Human | ACAT1 | PF | 33057949 | |
2349 | Alzheimer's Disease | SNP | rs2247071、rs2862616、rs3753526、rs1044925:CGGA Haplotype | Human | ACAT1 | RF | 33057949 | |
3152 | Alzheimer's Disease | SNP | rs4343 | Human | ACE | RF | in subjects aged 73 years and above. | 19539712 |
3835 | Parkinson disease | SNP | rs4646994 polymorphisms | Human | ACE | RF | 34945793 | |
3151 | Alzheimer's Disease | SNP | rs4293 | Human | ACE | RF | 21537449 | |
3153 | Alzheimer's Disease | SNP | rs1799752 | Human | ACE | RF | in subjects aged 73 years and above. | 19539712 |
2513 | Parkinson disease | SNP | rs1229984T allele | Human | ADH1B | RF | 30483881 | |
3155 | Alzheimer's Disease | SNP | rs4769874 A-allele and AA genotype | Human | ALOX5 | RF | 26944113 | |
2325 | Alzheimer's Disease | SNP | rs515071 polymorphism | Human | ANK1 | RF | 26611832 | |
3856 | Parkinson disease | SNP | rs2734849 GG homozygotes | Human | ANKK1 | RF | 34151861 | |
3156 | Alzheimer's Disease | SNP | rs4420638 polymorphisms | Human | APOC1 | RF | 30443289 | |
1656 | Alzheimer's Disease | SNP | rs12721046 | Human | APOC1 | RF | using Cox regression、Dataset:FHS(Framingham Heart Study) | 29107063 |
1670 | Alzheimer's Disease | SNP | rs12721046 | Human | APOC1 | RF | using Cox regression、Dataset:CHS(Cardiovascular Health Study) | 29107063 |
3157 | Alzheimer's Disease | SNP | rs11568822 polymorphism | Human | APOC1 | RF | not in African Americans | 24498013 |
2536 | Alzheimer's Disease | SNP | rs12721046 | Human | APOC1 | RF | using logistic regression、Dataset:FHS(Framingham Heart Study) | 29107063 |
3695 | Alzheimer's Disease | SNP | rs429358 | Human | APOE | RF | 34336000 | |
2976 | Alzheimer's Disease | SNP | rs429358, rs7412 | Human | APOE | RF | ε4 allele; AD without depression | 29703883 |
2894 | Alzheimer's Disease | SNP | rs429358, rs7412 | Human | APOE | RF | ε4 allele; AD all | 29703883 |
3014 | Alzheimer's Disease | SNP | rs429358, rs7412 | Human | APOE | RF | Genotype: ?3/?4; AD without depression | 29703883 |
2774 | Alzheimer's Disease | SNP | rs429358, rs7412 | Human | APOE | RF | Genotype: ?4/?4; AD without depression | 29703883 |
2601 | Alzheimer's Disease | SNP | rs449647 | Human | APOE | RF | A/A genotype | 19172988 |
2897 | Alzheimer's Disease | SNP | rs429358, rs7412 | Human | APOE | RF | Genotype: ?3/?4; AD all | 29703883 |
1572 | Alzheimer's Disease | SNP | rs405509 | Human | APOE | RF | using Cox regression、Dataset:CHS(Cardiovascular Health Study) | 29107063 |
625 | Alzheimer's Disease | SNP | rs449647 | Human | APOE | PF | Genotype/Allele: A/T | 29990559 |
2087 | Alzheimer's Disease | SNP | rs449647 | Human | APOE | RF | Genotype/Allele: A | 29990559 |
3115 | Alzheimer's Disease | SNP | rs429358 TC genotype | Human | APOE | RF | 35135450 | |
719 | Alzheimer's Disease | SNP | rs449647 | Human | APOE | PF | Genotype/Allele: T | 29990559 |
2734 | Alzheimer's Disease | SNP | L28P; rs769452 | Human | APOE | RF | with APOE*4?allele | 36528961 |
2463 | Alzheimer's Disease | SNP | rs429358 TT genotype | Human | APOE | RF | 35135450 | |
2298 | Alzheimer's Disease | SNP | rs449647 | Human | APOE | RF | Genotype/Allele: A/A | 29990559 |
2912 | Alzheimer's Disease | SNP | rs7412 TT genotype | Human | APOE | RF | 35135450 | |
2610 | Dementia with Lewy bodies | SNP | rs429358 | Human | APOE | RF | 29263008 | |
2260 | Alzheimer's Disease | SNP | rs405509 | Human | APOE | RF | using logistic regression、Dataset:LOADFS(Late Onset Alzheimer's Disease Family Study ) | 29107063 |
2368 | Alzheimer's Disease | SNP | rs769449 | Human | APOE | RF | using logistic regression、Dataset:HRS(Health and Retirement Study) | 29107063 |
1620 | Alzheimer's Disease | SNP | rs769449 | Human | APOE | RF | using Cox regression、Dataset:HRS(Health and Retirement Study) | 29107063 |
2113 | Alzheimer's Disease | SNP | rs405509 | Human | APOE | RF | using logistic regression、Dataset:CHS( Cardiovascular Health Study) | 29107063 |
2642 | Lewy Body Disease | SNP | rs429358 | Human | APOE?4 | RF | 34308904 | |
3914 | Alzheimer's Disease | SNP | NM_000484.3: c.2045A > T; p.E682V | Human | APP | RF | 37145212 | |
1800 | Alzheimer's Disease | SNP | rs1801278 | Human | Arg972 IRS1 | RF | A Allele | 24589556 |
1819 | Alzheimer's Disease | SNP | rs1801278 | Human | Arg972 IRS1 | RF | AA genotype | 24589556 |
1808 | Alzheimer's Disease | SNP | rs1801278 | Human | Arg972 IRS1 | RF | GA genotype | 24589556 |
3196 | Alzheimer's Disease | SNP | rs16933774 | Human | ASTN2 | RF | 25410587 | |
2580 | Alzheimer's Disease | SNP | rs732774 | Human | ATP10B | RF | 22950421 | |
2142 | Alzheimer's Disease | SNP | rs1801243 | Human | ATP7B | RF | 22950421 | |
2177 | Alzheimer's Disease | SNP | rs2147363 | Human | ATP8B | RF | 22950421 | |
2284 | Alzheimer's Disease | SNP | rs1061472 | Human | ATP9B | RF | 22950421 | |
3198 | Amyotrophic Lateral Sclerosis | SNP | rs179943 | Human | ATXN1 | RF | 25023141 | |
2413 | Alzheimer's Disease | SNP | rs638405,Val262 CC genotype | Human | BACE1 | RF | in carrying the ApoE epsilon4 allele | 18182766 |
1935 | Alzheimer's Disease | SNP | rs2837960 G allele | Human | BACE2 | RF | Rheumatoid arthritis (RA) RA-SNPs Association with AD | 21595938 |
3833 | Parkinson disease | SNP | rs6265 polymorphisms | Human | BDNF | RF | 34945793 | |
2353 | Alzheimer's Disease | SNP | rs2030324 | Human | BDNF C270T | RF | 26136901 | |
3205 | Alzheimer's Disease | SNP | rs744373 polymorphism | Human | BIN1 | RF | 26768592 | |
1920 | Alzheimer's Disease | SNP | rs744373 | Human | BIN1 | RF | Calculated by fixed effect model | 29504051 |
714 | Alzheimer's Disease | SNP | rs7561528 | Human | BIN1 | PF | National Alzheimer’s Coordinating Center (NACC) cohort | 30128317 |
1891 | Alzheimer's Disease | SNP | rs744373 | Human | BIN1 | RF | Calculated by fixed effect model | 29504051 |
1910 | Alzheimer's Disease | SNP | rs744373 | Human | BIN1 | RF | Calculated by fixed effect model | 29504051 |
3204 | Alzheimer's Disease | SNP | rs12989701 polymorphism | Human | BIN1 | RF | 26768592 | |
682 | Alzheimer's Disease | SNP | rs6733839 | Human | BIN1 | PF | National Alzheimer’s Coordinating Center (NACC) cohort | 30128317 |
1916 | Alzheimer's Disease | SNP | rs744373 | Human | BIN1 | RF | Calculated by random effect model | 29504051 |
1906 | Alzheimer's Disease | SNP | rs744373 | Human | BIN1 | RF | Calculated by random effect model | 29504051 |
2860 | Frontotemporal Lobar Degeneration | SNP | rs61707463 | Human | C4orf27 | RF | Discovery stage | 30739198 |
3206 | Amyotrophic Lateral Sclerosis | SNP | rs2708851 | Human | C7orf57 | RF | 25023141 | |
3207 | Amyotrophic Lateral Sclerosis | SNP | rs3849942 | Human | C9orf72 | RF | 25023141 | |
3051 | Parkinson disease | SNP | Intermediate repeat copies | Human | C9orf72 | RF | 23845100 | |
2409 | Amyotrophic Lateral Sclerosis | SNP | rs774359 | Human | C9orf72 | RF | 20801718 | |
729 | Creutzfeldt-Jakob disease | SNP | rs4918016 | Human | CALHM1 | PF | 22874670 | |
2544 | Creutzfeldt-Jakob disease | SNP | rs41287502 | Human | CALHM1 | RF | Genotype:GG | 22874670 |
1954 | Alzheimer's Disease | SNP | P86L polymorphism (rs2986017) | Human | CALHM1 | RF | 20061624 | |
3210 | Parkinson disease | SNP | rs12817488 polymorphism | Human | CCDC62/HIP1R | RF | 25818163 | |
1863 | Parkinson disease | SNP | GRCh38.p12chr17:34252593 G> C | Human | CCL2 | RF | 30761072 | |
1854 | Parkinson disease | SNP | rs1024611 variants (T>C) | Human | CCL2 | RF | 30761072 | |
926 | Parkinson disease | SNP | GA genotype, rs3826656 | Human | CD33 | PF | 37479176 | |
3954 | Parkinson disease | SNP | A allele, rs12985029 | Human | CD33 | RF | 37479176 | |
2162 | Alzheimer's Disease | SNP | rs2455069-A>G (R69G) | Human | CD33 | RF | 35408990 | |
815 | Alzheimer's Disease | SNP | rs3865444 A allele | Human | CD33 | PF | this association was not significant in Asians | 26795201 |
563 | Alzheimer's Disease | SNP | rs3826656 AA genotype | Human | CD33 | PF | in APOE e4 carriers | 22167654 |
901 | Parkinson disease | SNP | rs3865444 | Human | CD33 | PF | 33582190 | |
3213 | Alzheimer's Disease | SNP | rs3865444 T allele | Human | CD33 | RF | 22382309 | |
593 | Alzheimer's Disease | SNP | rs3826656 A allele | Human | CD33 | PF | in APOE e4 carriers | 22167654 |
3664 | Alzheimer's Disease | SNP | rs2455069-A> G | Human | CD33 | RF | 32647856 | |
2221 | Alzheimer's Disease | SNP | rs7755 | Human | CD36 | RF | Genotype: Recessive | 30235742 |
2477 | Alzheimer's Disease | SNP | rs7755 | Human | CD36 | RF | Genotype: GG; Adjusting the physiological and biochemical factors, including age, FBG, BMI, SBP, DBP, HDLC [According to univariate analysis, there was a significant deviation (P<0.05)]. | 30235742 |
2389 | Alzheimer's Disease | SNP | rs7755 | Human | CD36 | RF | Genotype: Dominant | 30235742 |
641 | Alzheimer's Disease | SNP | rs3211956 | Human | CD36 | PF | Genotype: GT | 30235742 |
630 | Alzheimer's Disease | SNP | rs3211956 | Human | CD36 | PF | Genotype: GT; Adjusting the physiological and biochemical factors, including age, FBG, BMI, SBP, DBP, HDLC [According to univariate analysis, there was a significant deviation (P<0.05)]. | 30235742 |
2598 | Alzheimer's Disease | SNP | rs7755 | Human | CD36 | RF | Genotype: GG | 30235742 |
2247 | Alzheimer's Disease | SNP | rs7755 | Human | CD36 | RF | Genotype: Dominant; Adjusting the physiological and biochemical factors, including age, FBG, BMI, SBP, DBP, HDLC [According to univariate analysis, there was a significant deviation (P<0.05)]. | 30235742 |
664 | Alzheimer's Disease | SNP | rs3211956 | Human | CD36 | PF | Genotype: Dominant; Adjusting the physiological and biochemical factors, including age, FBG, BMI, SBP, DBP, HDLC [According to univariate analysis, there was a significant deviation (P<0.05)]. | 30235742 |
681 | Alzheimer's Disease | SNP | rs3211956 | Human | CD36 | PF | Genotype: Dominant | 30235742 |
2203 | Alzheimer's Disease | SNP | rs2177369 (G>A) | Human | CHAT | RF | 27272392 | |
2236 | Alzheimer's Disease | SNP | rs3810950 (G>A) | Human | CHAT | RF | 27272392 | |
2878 | Amyotrophic Lateral Sclerosis | SNP | P413L | Human | CHGB | RF | 20007371 | |
2608 | Amyotrophic Lateral Sclerosis | SNP | P413L | Human | CHGB | RF | 20007371 | |
680 | Alzheimer's Disease | SNP | rs4950928 | Human | CHI3L1 | PF | CG+GG | 30223258 |
2551 | Alzheimer's Disease | SNP | rs10399931 | Human | CHI3L1 | RF | TT | 30223258 |
2127 | Alzheimer's Disease | SNP | rs10399931 | Human | CHI3L1 | RF | T allele | 30223258 |
687 | Alzheimer's Disease | SNP | rs4950928 | Human | CHI3L1 | PF | G allele | 30223258 |
2200 | Alzheimer's Disease | SNP | rs10399931 | Human | CHI3L1 | RF | CT+TT | 30223258 |
2595 | Creutzfeldt-Jakob disease | SNP | Human | CHN2 | RF | 22210626 | ||
3217 | Alzheimer's Disease | SNP | rs7294919 polymorphism | Human | chromosome 12q24.22 | RF | 24361131 | |
1991 | Alzheimer's Disease | SNP | rs1333049 | Human | chromosome 9p21.3 | RF | C allele | 19664850 |
2096 | Alzheimer's Disease | SNP | rs1333049 C allele | Human | chromosome 9p21.3 | RF | in non-APOE epsilon4 | 20427016 |
2336 | Alzheimer's Disease | SNP | rs1333049 polymorphism | Human | chromosome 9p21.3 | RF | 20427016 | |
502 | Alzheimer's Disease | SNP | rs9331888 GG+GC haplotypes | Human | CLU | PF | 26757186 | |
1858 | Alzheimer's Disease | SNP | rs11136000 | Human | CLU | RF | Calculated by fixed effect model | 29504051 |
1860 | Alzheimer's Disease | SNP | rs11136000 | Human | CLU | RF | Calculated by fixed effect model | 29504051 |
2922 | Alzheimer's Disease | SNP | rs1532278 GA genotype | Human | CLU | RF | 35135450 | |
1859 | Alzheimer's Disease | SNP | rs11136000 | Human | CLU | RF | Calculated by fixed effect model | 29504051 |
1856 | Alzheimer's Disease | SNP | rs11136000 | Human | CLU | RF | Calculated by random effect model | 29504051 |
2969 | Alzheimer's Disease | SNP | rs2279590 AA+GA haplotypes | Human | CLU | RF | 26757186 | |
2072 | Parkinson disease | SNP | rs9331896 TT genotype | Human | Clusterin (CLU) | RF | 33295114 | |
2377 | Tourette Syndrome | SNP | C allele of the rs2023239 | Human | CNR 1 | RF | 32194619 | |
2134 | Dementia with Lewy bodies | SNP | rs7314908 | Human | CNTN1 | RF | 29263008 | |
2097 | Amyotrophic Lateral Sclerosis | SNP | rs2619566 C Allele | Human | CNTN4 | RF | 34421992 | |
465 | Multiple System Atrophy | SNP | rs148156462 (TT) | Human | COQ2 | PF | 35748722 | |
1899 | Alzheimer's Disease | SNP | rs6656401 | Human | CR1 | RF | Calculated by fixed effect model | 29504051 |
747 | Alzheimer's Disease | SNP | rs6656401 | Human | CR1 | PF | National Alzheimer’s Coordinating Center (NACC) cohort | 30128317 |
1905 | Alzheimer's Disease | SNP | rs6656401 | Human | CR1 | RF | Calculated by fixed effect model | 29504051 |
633 | Alzheimer's Disease | SNP | rs6656401 | Human | CR1 | PF | PENN cohort | 30128317 |
1979 | Alzheimer's Disease | SNP | rs6656401 | Human | CR1 | RF | Calculated by fixed effect model | 29504051 |
3122 | Creutzfeldt-Jakob disease | SNP | rs17571 | Human | CTSD | RF | Genotype:CT | 18426579 |
2632 | Alzheimer's Disease | SNP | position 224 T-carrying genotype | Human | CTSD | RF | 24281128 | |
2424 | Creutzfeldt-Jakob disease | SNP | rs17571 | Human | CTSD | RF | Genotype:CC | 18426579 |
2651 | Amyotrophic Lateral Sclerosis | SNP | rs3732379 | Human | CX3CR1 | RF | 24806473 | |
2362 | Amyotrophic Lateral Sclerosis | SNP | rs3732379 | Human | CX3CR1 | RF | 24806473 | |
3230 | Amyotrophic Lateral Sclerosis | SNP | rs3732378 | Human | CX3CR1 | RF | 24806473 | |
3232 | Alzheimer's Disease | SNP | rs3751592 A/G polymorphism | Human | CYP19A1 | RF | 27583919 | |
2710 | Alzheimer's Disease | SNP | rs890293 | Human | CYP2J2 | RF | total;Genotype GT + TT | 25796175 |
2687 | Alzheimer's Disease | SNP | rs890293 | Human | CYP2J2 | RF | total;Allele T | 25796175 |
2259 | Alzheimer's Disease | SNP | rs754203 T allele | Human | CYP46A1 | RF | 22528464 | |
3790 | Amyotrophic lateral sclerosis,Parkinson disease | SNP | minor alleles of rs17115303 | Human | DAB1 | RF | 34707478 | |
753 | Alzheimer's Disease | SNP | C allele of rs4878104 | Human | DAPK1 | PF | especially the homozygotes | 21167819 |
3832 | Parkinson disease | SNP | rs2097629, rs1611115 polymorphisms | Human | DBH | RF | 34945793 | |
2920 | Frontotemporal Lobar Degeneration | SNP | rs4859146 | Human | DCUN1D1 | RF | Genotype:GG | 19473369 |
1783 | Alzheimer's Disease | SNP | rs12785878 T>C | Human | DHCR7 | RF | Chinese population | 33692822 |
3235 | Amyotrophic Lateral Sclerosis | SNP | rs16856202 | Human | DISC1 | RF | 25023141 | |
2128 | Parkinson disease | SNP | rs80315856 T allele | Human | DMRT2/SMARCA2 | RF | 33510632 | |
3236 | Parkinson disease | SNP | TT genotype and T allele of the 1254T>C polymorphism | Human | DMT1 | RF | 25817364 | |
892 | Parkinson disease | SNP | rs1451375 Polymorphisms | Human | DOPA decarboxylase gene (DDC) | PF | 33051953 | |
3237 | Amyotrophic Lateral Sclerosis | SNP | rs10260404 | Human | DPP6 | RF | 25023141 | |
2627 | Frontotemporal Lobar Degeneration | SNP | rs118113626 | Human | DPP6 | RF | Discovery stage | 30739198 |
693 | Amyotrophic Lateral Sclerosis | SNP | rs10260404 C Allele | Human | DPP6 | PF | 34421992 | |
2621 | Frontotemporal Lobar Degeneration | SNP | rs4726389 | Human | DPP6 | RF | Discovery stage | 30739198 |
2765 | Amyotrophic Lateral Sclerosis | SNP | rs147541241 | Human | DPYSL3(CRMP4) | RF | 23568759 | |
648 | Alzheimer's Disease | SNP | rs6557634;rs20575;rs20576 | Human | DR4 | PF | GGA haplotype | 25207117 |
830 | Alzheimer's Disease | SNP | rs6557634 | Human | DR4 | PF | the GA genotype | 25207117 |
2076 | Alzheimer's Disease | SNP | rs6557634;rs20575;rs20576 | Human | DR4 | RF | GCA haplotype | 25207117 |
504 | Alzheimer's Disease | SNP | rs6557634;rs20575;rs20576 | Human | DR4 | PF | GGC haplotype | 25207117 |
581 | Alzheimer's Disease | SNP | rs6557634;rs20575;rs20576 | Human | DR4 | PF | ACA haplotype | 25207117 |
2384 | Alzheimer's Disease | SNP | rs6557634;rs20575;rs20576 | Human | DR4 | RF | GCC haplotype | 25207117 |
3834 | Parkinson disease | SNP | rs6275, rs12364283, rs1076560 polymorphisms | Human | DRD2 | RF | 34945793 | |
779 | Progressive Supranuclear Palsy | SNP | rs6687758 | Human | DUSP10 | PF | Meta-analysis | 29986742 |
2278 | Parkinson disease | SNP | TT genotype derived from SNP rs8126696 | Human | DYRK1A | RF | especially for males | 27546826 |
2038 | Progressive Supranuclear Palsy | SNP | rs7571971 | Human | EIF2AK3 | RF | 33897612 | |
765 | Progressive Supranuclear Palsy | SNP | rs7571971 | Human | EIF2AK3 | PF | Meta-analysis | 29986742 |
2222 | Alzheimer's Disease | SNP | rs17247535 | Human | ENST00000414107 | RF | 29027019 | |
3240 | Amyotrophic Lateral Sclerosis | SNP | rs200746018 | Human | ERp57/PDIA3 | RF | 25913742 | |
653 | Alzheimer's Disease | SNP | rs3844508 | Human | ESR1 | PF | 20674091 | |
2372 | Alzheimer's Disease | SNP | rs10144225 G allele | Human | ESR2 | RF | predominantly Caucasian AIMS-defined ancestry | 24326520 |
2194 | Alzheimer's Disease | SNP | rs944045 G allele | Human | ESR2 | RF | predominantly Caucasian AIMS-defined ancestry | 24326520 |
2371 | Alzheimer's Disease | SNP | rs1256062 G allele | Human | ESR2 | RF | predominantly Caucasian AIMS-defined ancestry | 24326520 |
2195 | Alzheimer's Disease | SNP | rs2274705 G allele | Human | ESR2 | RF | predominantly Caucasian AIMS-defined ancestry | 24326520 |
678 | Alzheimer's Disease | SNP | rs10137185 T allele | Human | ESR3 | PF | 24326520 | |
1925 | Alzheimer's Disease | SNP | rs597668 C allele | Human | EXOC3L2 | RF | 28423615 | |
814 | Alzheimer's Disease | SNP | rs597668 C allele | Human | EXOC3L2 | PF | 28423615 | |
703 | Alzheimer's Disease | SNP | rs920608 C/A Allele | Human | FAM47E | PF | 33654092 | |
3242 | Parkinson disease | SNP | rs1721100 (C/G) polymorphism | Human | FGF20 | RF | 22342445 | |
1911 | Parkinson disease | SNP | rs1721100 GG genotype | Human | FGF20 | RF | 24942208 | |
3140 | Parkinson disease | SNP | rs12720208 polymorphism | Human | FGF20 | RF | 26070653 | |
3241 | Parkinson disease | SNP | rs12720208 polymorphism | Human | FGF20 | RF | 26070653 | |
3244 | Parkinson disease | SNP | rs1989754, ss20399075 | Human | FGF20 | RF | 15122513 | |
2246 | Alzheimer's Disease | SNP | rs7081208, rs2446581, rs17314229 AAC haplotype | Human | FRMD4A | RF | 22430674 | |
785 | Alzheimer's Disease | SNP | rs4945261 (G>A) | Human | GAB2 | PF | 26770425 | |
2032 | Alzheimer's Disease | SNP | C allele of the rs10793294 polymorphism | Human | GAB2 | RF | 21108942 | |
2471 | Alzheimer's Disease | SNP | C allele of rs7101429 | Human | GAB2 | RF | 21285854 | |
3247 | Alzheimer's Disease | SNP | T allele of rs4945261 | Human | GAB2 | RF | 21285854 | |
3127 | Alzheimer's Disease | SNP | rs2373115 polymorphism | Human | GAB2 | RF | a minor genetic determinant of AD | 18272374 |
792 | Alzheimer's Disease | SNP | rs2373115 (G>T) | Human | GAB2 | PF | 26770425 | |
3248 | Alzheimer's Disease | SNP | G allele of rs7115850 | Human | GAB2 | RF | 21285854 | |
1923 | Creutzfeldt-Jakob disease | SNP | rs2267161 | Human | GAL3ST1 | RF | 32949544 | |
2647 | Dementia with Lewy bodies | SNP | rs35749011 | Human | GBA | RF | 29263008 | |
1838 | Parkinson disease | SNP | rs3115534-G | Human | GBA1 | RF | 37633302 | |
2179 | Parkinson disease | SNP | rs3115534-G | Human | GBA1 | RF | 37633302 | |
2293 | Alzheimer's Disease | SNP | rs72713460 | Human | GCH1 | RF | 29432188 | |
3260 | Parkinson disease | SNP | RS11158026(T allele) polymorphism | Human | GCH1 | RF | 27871051 | |
1989 | Parkinson disease | SNP | Allele 'A' of rs797906 SNP | Human | GLIS1 | RF | 22759478 | |
2065 | Alzheimer's Disease | SNP | rs10868366 G allele | Human | GOLPH2 | RF | 22167654 | |
2066 | Alzheimer's Disease | SNP | rs7019241 C allele | Human | GOLPH2 | RF | 22167654 | |
3261 | Parkinson disease | SNP | rs4998386 T allele | Human | GRIN2A | RF | taking creatine who also have high levels of caffeine intake | 28320167 |
1489 | Frontotemporal Dementia | SNP | rs1042522 CC homozygous | Human | GRN | RF | 32972771 | |
2219 | Frontotemporal Lobar Degeneration | SNP | rs1990622 | Human | GRN | RF | more common (T) allele | 20154673 |
2808 | Frontotemporal Lobar Degeneration | SNP | rs5848 | Human | GRN | RF | Genotype:TT | 18723524 |
1934 | Alzheimer's Disease | SNP | rs5848 T allele | Human | GRN | RF | 26820675 | |
3815 | Lewy Body Disease | SNP | rs5848 | Human | GRN | RF | 34854996 | |
2798 | Amyotrophic Lateral Sclerosis | SNP | H63D(rs1799945) | Human | HFE | RF | Genotype:GC | 20642794 |
2845 | Amyotrophic Lateral Sclerosis | SNP | H63D(rs1799946) | Human | HFE | RF | Genotype:GC/GG | 20642794 |
683 | Parkinson disease | SNP | Cys282Tyr SNP | Human | HFE | PF | Australian PD patients | 12098643 |
2874 | Amyotrophic Lateral Sclerosis | SNP | H63D(rs1799947) | Human | HFE | RF | Genotype:G allele frequency | 20642794 |
684 | Parkinson disease | SNP | Cys282Tyr SNP | Human | HFE | PF | Australian PD patients | 12098643 |
3268 | Alzheimer's Disease | SNP | rs2075650 | Human | HIF3A | RF | eQTL(expression quantitative trait loci) analysis for the five SNPs closely related to AD | 30319691 |
2338 | Frontotemporal Lobar Degeneration | SNP | rs17219281 | Human | HLA-DQA2 | RF | Replication stage | 30739198 |
2486 | Frontotemporal Lobar Degeneration | SNP | rs17219281 | Human | HLA-DQA2 | RF | Discovery stage | 30739198 |
3269 | Parkinson disease | SNP | rs3129882 polymorphism | Human | HLA-DRA | RF | 25319953 | |
2738 | Amyotrophic Lateral Sclerosis | SNP | rs9268856 | Human | HLA-DRA/HLA-DRB5 | RF | the AA genotype at rs9268856 | 28131168 |
1931 | Alzheimer's Disease | SNP | the C allele at rs9271192 | Human | HLA-DRB1 | RF | non-APOE ε4 carriers with rs9271192 genotype CC;additive model | 29190991 |
2667 | Alzheimer's Disease | SNP | the C allele at rs9271192 | Human | HLA-DRB1 | RF | non-APOE ε4 carriers with rs9271192 genotype CC;recessive model | 29190991 |
533 | Frontotemporal Lobar Degeneration | SNP | rs61831315 | Human | HMCN1 | PF | Discovery stage | 30739198 |
2597 | Frontotemporal Lobar Degeneration | SNP | rs7967622 | Human | hnRNP-A1 | RF | C/C genotype | 21548758 |
2217 | Frontotemporal Lobar Degeneration | SNP | rs7967622 | Human | hnRNP-A1 | RF | C/C genotype | 21548758 |
554 | Alzheimer's Disease | SNP | rs1008438 | Human | HSP70/HSPA1A | PF | Genotype: A/C; AD without depression | 29703883 |
3272 | Parkinson disease | SNP | Promoter -819 T/C polymorphism | Human | IL-10 | RF | 22387064 | |
3271 | Parkinson disease | SNP | Promoter -819 T/C polymorphism | Human | IL-10 | RF | 21241672 | |
3273 | Parkinson disease | SNP | 607C/A (rs1946518) polymorphism | Human | IL-18 | RF | 21241672 | |
3275 | Alzheimer's Disease | SNP | rs1800587 polymorphism | Human | IL-1B | RF | 26768592 | |
3274 | Alzheimer's Disease | SNP | rs1143634 polymorphism | Human | IL-1B | RF | 26768592 | |
3276 | Alzheimer's Disease | SNP | rs1800587 ? 889C > T | Human | IL-1α | RF | 27014584 | |
3277 | Multiple System Atrophy | SNP | rs16944 | Human | IL-1β | RF | 29251119 | |
2201 | Frontotemporal Lobar Degeneration | SNP | rs10267171 | Human | IMMP2L | RF | Discovery stage | 30739198 |
2764 | Amyotrophic Lateral Sclerosis | SNP | rs79609816 T Allele | Human | INPP5B | RF | 34421992 | |
2280 | Alzheimer's Disease | SNP | rs3781239 C allele | Human | insulin degrading enzyme gene (IDE) | RF | 20880607 | |
2997 | Alzheimer's Disease | SNP | CC genotypes | Human | insulin degrading enzyme gene (IDE) | RF | CC genotype was significantly associated with earlier age at onset | 20880607 |
2832 | Amyotrophic Lateral Sclerosis | SNP | rs4363506 and rs16984239 | Human | Intergenic | RF | The estimations using the proposed method (unadjusted estimates) | 19740415 |
2787 | Amyotrophic Lateral Sclerosis | SNP | rs4363506 and rs16984239 | Human | Intergenic | RF | The estimations using the proposed method (adjusted estimates) | 19740415 |
2880 | Amyotrophic Lateral Sclerosis | SNP | rs4363506 and rs3733242 | Human | Intergenic and SHROOM3 | RF | The estimations using the proposed method (unadjusted estimates) | 19740415 |
2838 | Amyotrophic Lateral Sclerosis | SNP | rs4363506 and rs3733242 | Human | Intergenic and SHROOM4 | RF | The estimations using the proposed method (adjusted estimates) | 19740415 |
696 | Frontotemporal Lobar Degeneration | SNP | rs11132244 | Human | IRF2 | PF | Discovery stage | 30739198 |
2360 | Alzheimer's Disease | SNP | rs1143676 | Human | ITGA4 | RF | Codominant; Genotype/Allele: AG; Univariate analysis | 29769839 |
2242 | Alzheimer's Disease | SNP | rs1143676 | Human | ITGA4 | RF | Overdominant; Genotype/Allele: AG; Multivariate analysis | 29769839 |
2334 | Alzheimer's Disease | SNP | rs1143676 | Human | ITGA4 | RF | Overdominant; Genotype/Allele: AG; Univariate analysis | 29769839 |
2302 | Alzheimer's Disease | SNP | rs1143676 | Human | ITGA4 | RF | Dominant; Genotype/Allele: AG+GG; Univariate analysis | 29769839 |
2256 | Alzheimer's Disease | SNP | rs1143676 | Human | ITGA4 | RF | Dominant; Genotype/Allele: AG+GG; Multivariate analysis | 29769839 |
3278 | Amyotrophic Lateral Sclerosis | SNP | rs2306677 | Human | ITPR2 | RF | 25023141 | |
2181 | Alzheimer's Disease | SNP | rs928771 | Human | KCNJ15 | RF | 29432188 | |
574 | Alzheimer's Disease | SNP | rs17070145 polymorphism | Human | KIBRA | PF | 24190487 | |
3279 | Alzheimer's Disease | SNP | rs6850306 | Human | LCORL | RF | 29860282 | |
2108 | Alzheimer's Disease | SNP | rs688T/T genotype | Human | LDLR | RF | 18065781 | |
2149 | Alzheimer's Disease | SNP | rs7707505 | Human | LOC100505811 | RF | 29027019 | |
2091 | Alzheimer's Disease | SNP | rs7723042 | Human | LOC100505811 | RF | 29027019 | |
2183 | Alzheimer's Disease | SNP | rs7729428 | Human | LOC100505811 | RF | 29027019 | |
2180 | Alzheimer's Disease | SNP | rs7729996 | Human | LOC100505811 | RF | 29027019 | |
2105 | Frontotemporal Lobar Degeneration | SNP | rs6463679 | Human | LOC101927354 | RF | Discovery stage | 30739198 |
2526 | Amyotrophic Lateral Sclerosis | SNP | rs3849942 | Human | LOC107987057 | RF | 20801718 | |
1960 | Amyotrophic Lateral Sclerosis | SNP | rs3849942 | Human | LOC107987057 | RF | In the joint analysis | 20801717 |
2061 | Amyotrophic Lateral Sclerosis | SNP | rs3849942 | Human | LOC107987057 | RF | 20801717 | |
2057 | Amyotrophic Lateral Sclerosis | SNP | rs2814707 | Human | LOC107987057,LOC112268043 | RF | 20801717 | |
1961 | Amyotrophic Lateral Sclerosis | SNP | rs2814707 | Human | LOC107987057,LOC112268043 | RF | In the joint analysis | 20801717 |
2520 | Amyotrophic Lateral Sclerosis | SNP | rs2814707 | Human | LOC112268043,LOC107987057 | RF | 20801718 | |
2052 | Alzheimer's Disease | SNP | allele (A) of the rs3755166 polymorphism | Human | LRP2 | RF | 20971101 | |
805 | Parkinson disease | SNP | SNPs in rs10878226 | Human | LRRK2 | PF | 23115130 | |
3874 | Parkinson disease | SNP | rs1491942 | Human | LRRK2 | RF | 33574311 | |
1719 | Parkinson disease | SNP | rs34778348 G2385R variant | Human | LRRK2 | RF | 35733392 | |
1941 | Parkinson disease | SNP | SNPs in rs10878226 | Human | LRRK2 | RF | 23115130 | |
2682 | Parkinson disease | SNP | G2385R (c.7153G>A) | Human | LRRK2 | RF | 17314670 | |
3711 | Alzheimer's Disease | SNP | rs4768231,rs4767971,rs7307310,rs1465527 | Human | LRRK2 | RF | 34135785 | |
2491 | Amyotrophic Lateral Sclerosis | SNP | rs7403881 | Human | M1(C/C) | RF | 17503480 | |
555 | Amyotrophic Lateral Sclerosis | SNP | rs1875233 | Human | M5(A/A) | PF | 17503480 | |
2908 | Amyotrophic Lateral Sclerosis | SNP | rs2291957 | Human | M6(T/T) | RF | 17503480 | |
2379 | Multiple System Atrophy | SNP | rs1052553 | Human | MAPT | RF | H1 haplotype | 21321341 |
498 | Progressive Supranuclear Palsy | SNP | rs8070723 | Human | MAPT | PF | 33897612 | |
618 | Progressive Supranuclear Palsy | SNP | rs242557 | Human | MAPT | PF | Meta-analysis | 29986742 |
3037 | Progressive Supranuclear Palsy | SNP | rs8070723 | Human | MAPT | RF | Meta-analysis | 29986742 |
2582 | Progressive Supranuclear Palsy | SNP | rs242557 | Human | MAPT | RF | 33897612 | |
2783 | Frontotemporal Lobar Degeneration | SNP | p.A152T | Human | MAPT | RF | 22556362 | |
3288 | Frontotemporal Lobar Degeneration | SNP | Human | MFSD8 | RF | 30382371 | ||
3665 | Amyotrophic Lateral Sclerosis | SNP | c.695T> C(p.L232P) | Human | MFSD8 | RF | 33226711 | |
796 | Alzheimer's Disease | SNP | rs242557 G/A polymorphism | Human | microtubule-associated protein tau (MAPT) gene | PF | individuals with a GG genotype of rs242557G/A | 29098924 |
2129 | Frontotemporal Lobar Degeneration | SNP | rs4240777 | Human | MIR548AP | RF | Discovery stage | 30739198 |
3290 | Alzheimer's Disease | SNP | Human | MLKL | RF | MLKL loss-of-function mutation | 29656768 | |
2554 | Amyotrophic Lateral Sclerosis | SNP | rs2225389 | Human | MOB3B | RF | 20801718 | |
3291 | Amyotrophic Lateral Sclerosis | SNP | rs2225389 | Human | MOB3B | RF | 25023141 | |
3786 | Amyotrophic Lateral Sclerosis | SNP | rs616147 polymorphism | Human | MOBP | RF | Greece | 34694630 |
715 | Progressive Supranuclear Palsy | SNP | rs1768208 | Human | MOBP | PF | Meta-analysis | 29986742 |
2840 | Parkinson disease | SNP | rs1799836 G allele polymorphism | Human | Monoamine oxidase-B (MAO-B) | RF | levodopa-induced dyskinesia(LID) | 32346620 |
1888 | Alzheimer's Disease | SNP | rs670139 (G>T) | Human | MS4A4E | RF | 26770425 | |
3293 | Alzheimer's Disease | SNP | rs610932 C allele | Human | MS4A6A | RF | 22382309 | |
802 | Alzheimer's Disease | SNP | rs610932 (G>T) | Human | MS4A6A | PF | 26770425 | |
1857 | Alzheimer's Disease | SNP | rs610932 | Human | MS4A6A | RF | Calculated by fixed effect model | 29504051 |
1862 | Alzheimer's Disease | SNP | rs610932 | Human | MS4A6A | RF | Calculated by fixed effect model | 29504051 |
1861 | Alzheimer's Disease | SNP | rs610932 | Human | MS4A6A | RF | Calculated by fixed effect model | 29504051 |
2331 | Alzheimer's Disease | SNP | rs11754661 polymorphism A allele | Human | MTHFD1L | RF | the results were influenced by APOE status | 21741665 |
3294 | Alzheimer's Disease | SNP | both rs1801133 T and rs1800795 C alleles | Human | MTHFR | RF | increased the odds of developing AD by 2.5 | 22015309 |
1937 | Alzheimer's Disease | SNP | C677T allele | Human | MTHFR | RF | in APOE?4 or in non-APOE?4 carriers | 28211809 |
2648 | Amyotrophic Lateral Sclerosis | SNP | rs1801133 | Human | MTHFR(T677T) | RF | 22385294 | |
2748 | Amyotrophic Lateral Sclerosis | SNP | Human | MTHFR(T677T/A1298A) | RF | 22385294 | ||
3295 | Alzheimer's Disease | SNP | rs12506228A | Human | MTNR1A | RF | 29982836 | |
2639 | Parkinson disease | SNP | rs3738128 | Human | MUL1 | RF | 34946922 | |
2071 | Alzheimer's Disease | SNP | rs6797911 | Human | NEP gene (MME) | RF | 22493749 | |
575 | Alzheimer's Disease | SNP | Homozygosity of rs11833579 SNP | Human | NINJ2 | PF | 21674003 | |
541 | Alzheimer's Disease | SNP | Homozygosity of rs12425791 SNP | Human | NINJ2 | PF | 21674003 | |
2226 | Frontotemporal Lobar Degeneration | SNP | G894T (Glu298Asp) | Human | NOS3 | RF | 19087148 | |
2304 | Alzheimer's Disease | SNP | Human | NT-3 | RF | homozygotes or heterozygotes for the mutated type (Glu[-63]) | 9502217 | |
599 | Alzheimer's Disease | SNP | rs6489630 T allele | Human | NTF-3 | PF | in patients lacking the ApoE-?4 allele | 26814132 |
2287 | Frontotemporal Lobar Degeneration | SNP | rs13283101 | Human | OLFM1 | RF | Discovery stage | 30739198 |
3085 | Parkinson disease | SNP | IVS5+29T>A variant | Human | Omi/HTRA2 | RF | 21338583 | |
2036 | Alzheimer's Disease | SNP | rs1497525 | Human | OR2B2 | RF | 33654092 | |
3300 | Alzheimer's Disease | SNP | rs2653349(GA+AA) genotype | Human | OX2R | RF | A allele may be a susceptible factor for AD | 30955315 |
3301 | Alzheimer's Disease | SNP | rs2292041 A allele | Human | OX2R | RF | A allele may be a susceptible factor for AD | 30955315 |
3137 | Alzheimer's Disease | SNP | rs1050283 SNP | Human | oxidized LDL receptor 1(OLR1) | RF | 21709374 | |
3126 | Alzheimer's Disease | SNP | rs1050283 SNP | Human | oxidized LDL receptor 1(OLR1) | RF | 21709374 | |
3302 | Parkinson disease | SNP | Receptors gene 1513A>C polymorphism | Human | P2X7 | RF | 23648388 | |
3303 | Amyotrophic Lateral Sclerosis | SNP | rs145209834,rs138621837,rs200458051,rs200655529,rs143647285 | Human | P4HB/PDIA1 | RF | 25913742 | |
3851 | Parkinson disease | SNP | rs11240572 | Human | PARK16 | RF | 34373950 | |
3304 | Parkinson disease | SNP | rs823128, rs823156, and rs11240572 | Human | PARK16 | RF | 27174169 | |
2396 | Parkinson disease | SNP | rs947211 G/G genotype | Human | PARK16 | RF | 21419001 | |
728 | Parkinson disease | SNP | rs947211 | Human | PARK16 | PF | 27174169 | |
1853 | Tourette Syndrome | SNP | rs17371795 | Human | PCNT | RF | 32099372 | |
1855 | Tourette Syndrome | SNP | rs2839228 | Human | PCNT | RF | 32099372 | |
1852 | Tourette Syndrome | SNP | rs2839227 | Human | PCNT | RF | 32099372 | |
2103 | Alzheimer's Disease | SNP | G523A A allele | Human | PEMT | RF | 21881829 | |
2545 | Amyotrophic Lateral Sclerosis | SNP | rs140547520 | Human | PFN1 | RF | 24309268 | |
2352 | Alzheimer's Disease | SNP | rs561655 | Human | PICALM | RF | PENN cohort | 30128317 |
2508 | Alzheimer's Disease | SNP | rs3851179 | Human | PICALM | RF | PENN cohort | 30128317 |
752 | Parkinson disease | SNP | rs28499371 T allele | Human | PLEKHN1 | PF | 33510632 | |
832 | Alzheimer's Disease | SNP | Human | PM20D1 | PF | in a particular genetic background | 29736028 | |
3995 | Charcot-Marie-Tooth (CMT) disease | SNP | T118M variation | Human | PMP22 | RF | 36581210 | |
2390 | Amyotrophic Lateral Sclerosis | SNP | rs662 | Human | PON1 Q192R(major allele is Q) | RF | Recessive (RR vs other) | 16822965 |
2086 | Amyotrophic Lateral Sclerosis | SNP | rs662 | Human | PON1 Q192R(major allele is Q) | RF | Additive | 16822965 |
2132 | Amyotrophic Lateral Sclerosis | SNP | rs6954345 | Human | PON2 C311S (major allele is S) | RF | Dominant (CC and CS vs SS) | 16822965 |
2046 | Amyotrophic Lateral Sclerosis | SNP | rs6954345 | Human | PON2 C311S (major allele is S) | RF | Additive | 16822965 |
2484 | Creutzfeldt-Jakob disease | SNP | rs2756271 | Human | PRNP | RF | 22210626 | |
2918 | Creutzfeldt-Jakob disease | SNP | rs6107516 | Human | PRNP | RF | 19081515 | |
2882 | Creutzfeldt-Jakob disease | SNP | rs6116492 | Human | PRNP | RF | 19081515 | |
3004 | Creutzfeldt-Jakob disease | SNP | M129V MM heterozygote | Human | PRNP | RF | 34831353 | |
2166 | Creutzfeldt-Jakob disease | SNP | rs638405 | Human | PRNP | RF | BACE1?C-allele carriers | 22952813 |
2405 | Creutzfeldt-Jakob disease | SNP | rs638405 | Human | PRNP | RF | BACE1?C-allele carriers | 22952813 |
3318 | Alzheimer's Disease | SNP | Human | PS-1 | RF | 9298817 | ||
3928 | Alzheimer's Disease | SNP | rs756609078 Thr421Met | Human | PSEN2 | RF | 36362122 | |
763 | Alzheimer's Disease | SNP | rs28834970 | Human | PTK2B | PF | National Alzheimer’s Coordinating Center (NACC) cohort | 30128317 |
3791 | Amyotrophic lateral sclerosis,Parkinson disease | SNP | rs6030462 | Human | PTPRT | RF | 34707478 | |
1573 | Alzheimer's Disease | SNP | rs6859 | Human | PVRL2 | RF | using Cox regression、Dataset:CHS(Cardiovascular Health Study) | 29107063 |
3324 | Alzheimer's Disease | SNP | rs2075650 | Human | PVRL2 | RF | eQTL(expression quantitative trait loci) analysis for the five SNPs closely related to AD | 30319691 |
2261 | Alzheimer's Disease | SNP | rs6859 | Human | PVRL2 | RF | using logistic regression、Dataset:LOADFS(Late Onset Alzheimer's Disease Family Study ) | 29107063 |
2114 | Alzheimer's Disease | SNP | rs283815 | Human | PVRL2 | RF | using logistic regression、Dataset:HRS(Health and Retirement Study) | 29107063 |
2064 | Alzheimer's Disease | SNP | rs6859 | Human | PVRL2 | RF | using logistic regression、Dataset:CHS( Cardiovascular Health Study) | 29107063 |
3323 | Alzheimer's Disease | SNP | rs769449 | Human | PVRL2 | RF | eQTL(expression quantitative trait loci) analysis for the five SNPs closely related to AD | 30319691 |
3325 | Alzheimer's Disease | SNP | rs157580 | Human | PVRL2 | RF | eQTL(expression quantitative trait loci) analysis for the five SNPs closely related to AD | 30319691 |
2058 | Alzheimer's Disease | SNP | A80G GG genotype | Human | reduced folate carrier gene (RFC1) | RF | especially for female individuals | 18258338 |
2019 | Alzheimer's Disease | SNP | A80G G allele | Human | reduced folate carrier gene (RFC1) | RF | especially for female individuals | 18258338 |
700 | Frontotemporal Lobar Degeneration | SNP | rs12425381 | Human | RERG | PF | Discovery stage | 30739198 |
3329 | Parkinson disease | SNP | rs62063857 AA genotype | Human | Saitohin | RF | 25168738 | |
833 | Parkinson disease | SNP | rs62063857 AG genotype | Human | Saitohin | PF | 25168738 | |
798 | Parkinson disease | SNP | rs7702187 polymorphism | Human | SEMA5A | PF | 24706317 | |
3106 | Alzheimer's Disease | SNP | rs1799889 4G/4G genotype | Human | SERPINE1 | RF | women were at an increased risk over their male genotype counterparts | 28466654 |
2965 | Alzheimer's Disease | SNP | rs1799889 4G/5G genotype | Human | SERPINE1 | RF | women were at an increased risk over their male genotype counterparts | 28466654 |
3052 | Alzheimer's Disease | SNP | rs572750141 variant (NM_030974.3:p.Gly186Arg) | Human | SHARPIN | RF | 31216982 | |
2227 | Alzheimer's Disease | SNP | rs10410544 T allele | Human | SIRT2 | RF | APOEε4 noncarriers | 24139700 |
3332 | Alzheimer's Disease | SNP | rs10410544 C/T polymorphism | Human | SIRT2 | RF | 24139700 | |
1982 | Parkinson disease | SNP | Genotype allele G of the promoter SNP rs2652510 | Human | SLC6A3 | RF | 24211691 | |
2051 | Parkinson disease | SNP | Genotype GG of the promoter SNP rs2652510 | Human | SLC6A3 | RF | 24211691 | |
1981 | Parkinson disease | SNP | Genotype allele G of the promoter SNP rs2652510 | Human | SLC6A3 | RF | 24211691 | |
2050 | Parkinson disease | SNP | Genotype GG of the promoter SNP rs2652510 | Human | SLC6A3 | RF | 24211691 | |
578 | Alzheimer's Disease | SNP | rs4795541 | Human | SLC6A4/5-HTT | PF | S allele; AD with depression | 29703883 |
709 | Progressive Supranuclear Palsy | SNP | rs11568563 | Human | SLCO1A2 | PF | Meta-analysis | 29986742 |
3994 | Spinal muscular atrophy (SMA) | SNP | rs121909192 | Human | SMN1 | RF | 37964750 | |
708 | Parkinson disease | SNP | rs11931074 | Human | SNCA | PF | 34946922 | |
2047 | Lewy Body Disease | SNP | rs7681440 | Human | SNCA | RF | 34308904 | |
742 | Dementia with Lewy bodies | SNP | rs7681440; | Human | SNCA | PF | 29263008 | |
3142 | Parkinson disease | SNP | rs356220, rs356203, rs7684318 and rs2736990 polymorphism | Human | SNCA | RF | 27699750 | |
2357 | Parkinson disease | SNP | rs356219 variant | Human | SNCA | RF | 22349157 | |
3129 | Parkinson disease | SNP | rs7684318 C-allele | Human | SNCA | RF | 33705925 | |
590 | Alzheimer's Disease | SNP | rs2070424 | Human | SOD1 gene | PF | Logistic regression analysis controlled for age, genderand APOE carrier status;recessive model | 25440013 |
627 | Alzheimer's Disease | SNP | rs2070424 | Human | SOD1 gene | PF | After Bonferroni correction;additive model | 25440013 |
589 | Alzheimer's Disease | SNP | rs2070424 | Human | SOD1 gene | PF | Logistic regression analysis controlled for age, genderand APOE carrier status;additive model | 25440013 |
637 | Alzheimer's Disease | SNP | rs2070424 | Human | SOD1 gene | PF | After Bonferroni correction;recessive model | 25440013 |
3916 | Alzheimer's Disease | SNP | NM_003105.6: c.4519+5G>A | Human | SORL1 | RF | 35457051 | |
2404 | Alzheimer's Disease | SNP | SNP rs985421 A allele | Human | SORL1 | RF | 24486888 | |
3706 | Alzheimer's Disease | SNP | rs3737529 | Human | SORL1 | RF | 34214049 | |
834 | Alzheimer's Disease | SNP | Human | SORL1 | PF | 18407551 | ||
3908 | Alzheimer's Disease | SNP | rs1784933 A/A genotype | Human | SORL1 | RF | 35456392 | |
2059 | Alzheimer's Disease | SNP | rs641120 | Human | SORL1 | RF | adjusted for age and gender | 25881907 |
2053 | Alzheimer's Disease | SNP | rs641120 | Human | SORL1 | RF | adjusted foe age, gender, APOE 4 | 25881907 |
3915 | Alzheimer's Disease | SNP | rs775517202 c.364C>T | Human | SORL1 | RF | 35457051 | |
3337 | Alzheimer's Disease | SNP | rs1784933 | Human | SORL1 | RF | with the A allele | 25450149 |
823 | Alzheimer's Disease | SNP | Human | SORL1 | PF | 30009200 | ||
674 | Alzheimer's Disease | SNP | rs17646665 GA Genotype | Human | SORT1 | PF | 27392867 | |
3341 | Alzheimer's Disease | SNP | rs2269657 | Human | SREBF2 | RF | significant dual associations with LOAD pathological biomarkers and gene expression levels | 29503034 |
2529 | Alzheimer's Disease | SNP | rs10164112-T allele | Human | STARD6 | RF | in combination with the APOE ε4 allele | 30666118 |
2218 | Parkinson disease | SNP | rs1955337 TT genotype | Human | STK39 | RF | 26469904 | |
775 | Progressive Supranuclear Palsy | SNP | rs1411478 | Human | STX6 | PF | Meta-analysis | 29986742 |
3343 | Amyotrophic Lateral Sclerosis | SNP | rs2708909 | Human | SUN3, HUS1 | RF | 25023141 | |
3344 | Alzheimer's Disease | SNP | rs4420638 | Human | SYMPK | RF | eQTL(expression quantitative trait loci) analysis for the five SNPs closely related to AD | 30319691 |
3345 | Amyotrophic Lateral Sclerosis | SNP | rs80356717 | Human | TARDBP | RF | 25023141 | |
3346 | Frontotemporal Lobar Degeneration | SNP | c.269C>T (p.A90V) | Human | TARDBP | RF | 18505686 | |
2310 | Parkinson disease | SNP | rs2306604 G/G genotype | Human | TFAM | RF | 19925850 | |
2311 | Alzheimer's Disease | SNP | rs1982073 | Human | TGF-β1 | RF | without the ApoE ε4 allele;G | 26327336 |
2363 | Alzheimer's Disease | SNP | rs1982073 | Human | TGF-β1 | RF | without the ApoE ε4 allele;TG | 26327336 |
2081 | Alzheimer's Disease | SNP | rs1982073 | Human | TGF-β1 | RF | allele G | 26327336 |
2238 | Alzheimer's Disease | SNP | rs1800469 | Human | TGF-β1 | RF | allele C | 26327336 |
2160 | Alzheimer's Disease | SNP | rs1800469 | Human | TGF-β1 | RF | without the ApoE ε4allele;C | 26327336 |
2229 | Alzheimer's Disease | SNP | rs1982073 | Human | TGF-β1 | RF | Genotype TG | 26327336 |
2472 | Alzheimer's Disease | SNP | rs1800469 | Human | TGF-β1 | RF | Genotype AC | 26327336 |
2713 | Alzheimer's Disease | SNP | rs1800469 | Human | TGF-β1 | RF | AC+ CC vs AA | 26327336 |
2270 | Alzheimer's Disease | SNP | rs1800469 | Human | TGF-β1 | RF | without the ApoE ε4 allele;AC | 26327336 |
3352 | Amyotrophic Lateral Sclerosis | SNP | rs13048019 | Human | TIAM1 | RF | 25023141 | |
2481 | Amyotrophic Lateral Sclerosis | SNP | rs13048019 | Human | TIAM1 | RF | 20801718 | |
835 | Alzheimer's Disease | SNP | minor alleles of seven SNPs (rs10759930, rs1927914, rs1927911, rs12377632, rs2149356, rs7037117, and rs7045953) | Human | TLR4 | PF | when incorporated into a haplotype with rs10759930, the strongest association was detected | 22272615 |
2479 | Frontotemporal Lobar Degeneration | SNP | rs3849942 | Human | TMEM106B | RF | for chromosome 9 SNP association; Denotes the associated SNP’s from the GWAS. | 21257233 |
837 | Frontotemporal Dementia | SNP | rs1990622 | Human | TMEM106B | PF | C9ORF72 expansion carriers;Cohort 1 – controls and C9ORF72 repeat expansion carriers (FTD, FTD/MND, and MND, or other diagnosis) | 24385136 |
3814 | Lewy Body Disease | SNP | rs1990622 | Human | TMEM106B | RF | 34854996 | |
2512 | Frontotemporal Lobar Degeneration | SNP | rs10812605 | Human | TMEM106B | RF | for chromosome 9 SNP association | 21257233 |
2235 | Frontotemporal Lobar Degeneration | SNP | rs2015747 | Human | TMEM106B | RF | for chromosome 1 SNP association | 21257233 |
2318 | Frontotemporal Lobar Degeneration | SNP | rs774351 | Human | TMEM106B | RF | for chromosome 9 SNP association; Denotes the associated SNP’s from the GWAS. | 21257233 |
662 | Frontotemporal Lobar Degeneration | SNP | rs1990622 | Human | TMEM106B | PF | GRN carriers | 25085782 |
2489 | Frontotemporal Lobar Degeneration | SNP | rs868856 | Human | TMEM106B | RF | for chromosome 9 SNP association | 21257233 |
2942 | Frontotemporal Lobar Degeneration | SNP | rs12350089 | Human | TMEM106B | RF | for chromosome 9 SNP association | 21257233 |
668 | Frontotemporal Lobar Degeneration | SNP | rs2015747 | Human | TMEM106B | PF | for SNPs on chromosomes 1, 8, 10 and 11 genotyped | 21257233 |
3777 | Amyotrophic Lateral Sclerosis | SNP | rs1990622 A/A | Human | TMEM106B | RF | 33314436 | |
836 | Frontotemporal Dementia | SNP | rs3173615 | Human | TMEM106B | PF | C9ORF72 expansion carriers;Cohort 1 – controls and C9ORF72 repeat expansion carriers (FTD, FTD/MND, and MND, or other diagnosis) | 24385136 |
2553 | Frontotemporal Lobar Degeneration | SNP | rs2814707 | Human | TMEM106B | RF | for chromosome 9 SNP association; Denotes the associated SNP’s from the GWAS;Denotes the associated SNP’s from the ALS GWAS | 21257233 |
3798 | Frontotemporal Lobar Degeneration | SNP | rs1990622 A/A genotype | Human | TMEM106B | RF | 33314436 | |
2317 | Frontotemporal Lobar Degeneration | SNP | rs1565948 | Human | TMEM106B | RF | for chromosome 9 SNP association | 21257233 |
2244 | Frontotemporal Lobar Degeneration | SNP | rs10967976 | Human | TMEM106B | RF | for chromosome 9 SNP association | 21257233 |
2549 | Frontotemporal Lobar Degeneration | SNP | rs10967959 | Human | TMEM106B | RF | for chromosome 9 SNP association | 21257233 |
1849 | Frontotemporal Lobar Degeneration | SNP | rs2015747 | Human | TMEM106B | RF | for chromosome 1 SNP association | 21257233 |
2607 | Frontotemporal Lobar Degeneration | SNP | rs774352 | Human | TMEM106B | RF | for chromosome 9 SNP association; Denotes the associated SNP’s from the GWAS. | 21257233 |
3353 | Alzheimer's Disease | SNP | rs1990622 polymorphism | Human | TMEM106B | RF | APOE interact | 24166182 |
3354 | Alzheimer's Disease | SNP | rs12435391(IVS4-28T> C) | Human | TMP21 | RF | 28233271 | |
2358 | Multiple System Atrophy | SNP | rs1799964 | Human | TNF-α | RF | allele | 29251119 |
1968 | Multiple System Atrophy | SNP | rs1799964 | Human | TNF-α | RF | genotype | 29251119 |
2885 | Alzheimer's Disease | SNP | rs10119 GG genotype | Human | TOMM40 | RF | APOE ε4+ | 32725468 |
2564 | Alzheimer's Disease | SNP | rs2075650 | Human | TOMM40 | RF | using logistic regression、Dataset:CHS( Cardiovascular Health Study) | 29107063 |
690 | Alzheimer's Disease | SNP | rs157580 A allele | Human | TOMM40 | PF | the association between the Asian and Caucasian groups was significantly different | 26795201 |
2735 | Alzheimer's Disease | SNP | rs2075650 A allele | Human | TOMM40 | RF | the association between the Asian and Caucasian groups was significantly different | 26795201 |
2115 | Alzheimer's Disease | SNP | rs157582 | Human | TOMM40 | RF | using logistic regression、Dataset:HRS(Health and Retirement Study) | 29107063 |
3356 | Alzheimer's Disease | SNP | rs2075650 | Human | TOMM40 | RF | 29797398 | |
1589 | Alzheimer's Disease | SNP | rs71352238 | Human | TOMM40 | RF | using Cox regression、Dataset:HRS(Health and Retirement Study) | 29107063 |
1621 | Alzheimer's Disease | SNP | rs2075650 | Human | TOMM40 | RF | using Cox regression、Dataset:FHS(Framingham Heart Study) | 29107063 |
2565 | Alzheimer's Disease | SNP | rs2075650 | Human | TOMM40 | RF | using logistic regression、Dataset:FHS(Framingham Heart Study) | 29107063 |
1588 | Alzheimer's Disease | SNP | rs2075650 | Human | TOMM40 | RF | using Cox regression、Dataset:HRS(Health and Retirement Study) | 29107063 |
3696 | Alzheimer's Disease | SNP | rs2075650 | Human | TOMM40 | RF | 34336000 | |
2184 | Alzheimer's Disease | SNP | rs71352238 | Human | TOMM40 | RF | using logistic regression、Dataset:HRS(Health and Retirement Study) | 29107063 |
2964 | Alzheimer's Disease | SNP | rs71352238 CT genotype | Human | TOMM40 | RF | APOE ε4+ | 32725468 |
2116 | Alzheimer's Disease | SNP | rs2075650 | Human | TOMM40 | RF | using logistic regression、Dataset:HRS(Health and Retirement Study) | 29107063 |
3357 | Alzheimer's Disease | SNP | rs157580 | Human | TOMM40 | RF | 29797398 | |
2896 | Alzheimer's Disease | SNP | rs71352238 TT genotype | Human | TOMM40 | RF | APOE ε4+ | 32725468 |
2935 | Alzheimer's Disease | SNP | rs10119 AG genotype | Human | TOMM40 | RF | APOE ε4+ | 32725468 |
1673 | Alzheimer's Disease | SNP | rs2075650 | Human | TOMM40 | RF | using Cox regression、Dataset:CHS(Cardiovascular Health Study) | 29107063 |
2862 | Alzheimer's Disease | SNP | rs2075650 | Human | TOMM40 | RF | using logistic regression、Dataset:LOADFS(Late Onset Alzheimer's Disease Family Study ) | 29107063 |
2445 | Alzheimer's Disease | SNP | rs10119 AA genotype | Human | TOMM40 | RF | APOE ε4+ | 32725468 |
1488 | Frontotemporal Dementia | SNP | rs1042522 | Human | TP53 | RF | 32972771 | |
3011 | Frontotemporal Dementia | SNP | rs75932628(p.R47H) | Human | TREM2 | RF | 23800361 | |
3360 | Alzheimer's Disease | SNP | rs75932628 | Human | TREM2 | RF | 29794134 | |
2679 | Frontotemporal Lobar Degeneration | SNP | rs2234253 | Human | TREM2 | RF | carrier T vs. G | 29322490 |
3366 | Frontotemporal Lobar Degeneration | SNP | rs754650868 | Human | TREM2 | RF | 29557178 | |
2703 | Alzheimer's Disease | SNP | rs75932628 | Human | TREM2 | RF | 26037549 | |
2928 | Alzheimer's Disease | SNP | rs75932628(T variant ) | Human | TREM2 | RF | 23380991 | |
2609 | Amyotrophic Lateral Sclerosis | SNP | rs75932628 | Human | TREM2 | RF | 24535663 | |
3363 | Frontotemporal Lobar Degeneration | SNP | rs201258314 | Human | TREM2 | RF | Compound heterozygosity | 29557178 |
2681 | Frontotemporal Lobar Degeneration | SNP | rs2234253 | Human | TREM2 | RF | GT+TT vs. GG | 29322490 |
2933 | Alzheimer's Disease | SNP | rs75932628-T(p.R47H) variant | Human | TREM2 | RF | 24041969 | |
2534 | Alzheimer's Disease | SNP | p.R47H (rs75932628) | Human | TREM2 | RF | 25160042 | |
2617 | Frontotemporal Lobar Degeneration | SNP | rs75932628 | Human | TREM2 | RF | T vs. C | 29322490 |
2427 | Alzheimer's Disease | SNP | rs75932628 | Human | TREM2 | RF | the T allele of the rs75932628 variant of TREM2 | 25260849 |
3359 | Alzheimer's Disease | SNP | rs75932628 | Human | TREM2 | RF | 30222607 | |
2559 | Frontotemporal Lobar Degeneration | SNP | rs75932628 | Human | TREM2 | RF | CT vs. CC | 29322490 |
2678 | Frontotemporal Lobar Degeneration | SNP | rs2234253 | Human | TREM2 | RF | T vs. G | 29322490 |
3365 | Frontotemporal Lobar Degeneration | SNP | rs201258663 | Human | TREM2 | RF | Compound heterozygosity | 29557178 |
3012 | Frontotemporal Lobar Degeneration | SNP | rs75932628 | Human | TREM2 | RF | 23800361 | |
3362 | Frontotemporal Lobar Degeneration | SNP | Human | TREM2 | RF | A large consanguineous Colombian family segregating autosomal recessive FTLD | 23582655 | |
2680 | Frontotemporal Lobar Degeneration | SNP | rs2234253 | Human | TREM2 | RF | GT vs. GG | 29322490 |
3367 | Frontotemporal Lobar Degeneration | SNP | rs142232675 | Human | TREM2 | RF | Homozygosity | 29557178 |
2704 | Alzheimer's Disease | SNP | rs75932628 | Human | TREM2 | RF | 25936935 | |
2932 | Alzheimer's Disease | SNP | rs75932628-T(p.R47H) variant | Human | TREM2 | RF | 24041969 | |
2849 | Alzheimer's Disease | SNP | rs75932628 (R47H) variant | Human | TREM2 | RF | 23855982 | |
2558 | Frontotemporal Lobar Degeneration | SNP | rs75932628 | Human | TREM2 | RF | CT+TT vs. CC | 29322490 |
3364 | Frontotemporal Lobar Degeneration | SNP | rs143332484 | Human | TREM2 | RF | 29557178 | |
2552 | Frontotemporal Lobar Degeneration | SNP | rs75932628 | Human | TREM2 | RF | carrier T vs. C | 29322490 |
2958 | Multiple System Atrophy | SNP | rs75932628 | Human | TREM2 p.R47H | RF | patients with pathologically confirmed MSA | 30109269 |
1817 | Multiple System Atrophy | SNP | rs75932628 | Human | TREM2 p.R47H | RF | patients with pathologically confirmed MSA | 30109269 |
1813 | Multiple System Atrophy | SNP | rs75932628 | Human | TREM2 p.R47H | RF | patients with clinically diagnosed MSA | 30109269 |
2893 | Multiple System Atrophy | SNP | rs75932628 | Human | TREM2 p.R47H | RF | patients with clinically diagnosed MSA | 30109269 |
2173 | Parkinson disease | SNP | AA genotype of UCHL1 S18Y SNP | Human | UCHL1 | RF | 22839974 | |
2171 | Frontotemporal Lobar Degeneration | SNP | rs12973192 | Human | UNC13A | RF | Replication stage | 30739198 |
1904 | Amyotrophic Lateral Sclerosis | SNP | rs12608932 | Human | UNC13A | RF | especially in Caucasian and European subjects | 31201598 |
2099 | Frontotemporal Lobar Degeneration | SNP | rs12973192 | Human | UNC13A | RF | Discovery stage | 30739198 |
2049 | Frontotemporal Lobar Degeneration | SNP | -2578 C/A | Human | VEGF | RF | A allele | 18729809 |
2112 | Parkinson disease | SNP | rs3025039 polymorphism | Human | VEGF | RF | 27481110 | |
2020 | Frontotemporal Lobar Degeneration | SNP | -1154 G/A | Human | VEGF | RF | A allele | 18729809 |
3853 | Parkinson disease | SNP | FokI (rs2228570) T allele | Human | vitamin D Receptor(VDR) | RF | 34365149 | |
3852 | Parkinson disease | SNP | FokI (rs2228570) T allele and TT genotype | Human | vitamin D Receptor(VDR) | RF | 34365149 | |
3854 | Parkinson disease | SNP | rs1989969 GCTG haplotype | Human | vitamin D Receptor(VDR) | RF | 34365149 | |
3371 | Parkinson disease | SNP | rs363324 at -11.5 kb in the hVMAT2 promoter | Human | VMAT2 | RF | 27137201 | |
740 | Parkinson disease | SNP | rs863108 T allele | Human | ZFP64/TSHZ2 | PF | 33510632 | |
3779 | Amyotrophic Lateral Sclerosis | SNP | rs2275294-C allele | Human | ZNF512B | RF | 33387304 |
|
All rights reserved: Institutes for Systems Genetics, West China Hospital
|